AMLX
Price
$10.20
Change
+$0.25 (+2.51%)
Updated
Sep 5 closing price
Capitalization
909.51M
61 days until earnings call
ANVS
Price
$2.29
Change
+$0.01 (+0.44%)
Updated
Sep 5 closing price
Capitalization
44.62M
60 days until earnings call
Interact to see
Advertisement

AMLX vs ANVS

Header iconAMLX vs ANVS Comparison
Open Charts AMLX vs ANVSBanner chart's image
Amylyx Pharmaceuticals
Price$10.20
Change+$0.25 (+2.51%)
Volume$1.75M
Capitalization909.51M
Annovis Bio
Price$2.29
Change+$0.01 (+0.44%)
Volume$169.32K
Capitalization44.62M
AMLX vs ANVS Comparison Chart in %
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. ANVS commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a StrongBuy and ANVS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AMLX: $10.20 vs. ANVS: $2.29)
Brand notoriety: AMLX and ANVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 125% vs. ANVS: 63%
Market capitalization -- AMLX: $909.51M vs. ANVS: $44.62M
AMLX [@Biotechnology] is valued at $909.51M. ANVS’s [@Biotechnology] market capitalization is $44.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileANVS’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • ANVS’s FA Score: 1 green, 4 red.
According to our system of comparison, AMLX is a better buy in the long-term than ANVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 3 TA indicator(s) are bullish while ANVS’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 3 bullish, 4 bearish.
  • ANVS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both AMLX and ANVS are a bad buy in the short-term.

Price Growth

AMLX (@Biotechnology) experienced а +8.74% price change this week, while ANVS (@Biotechnology) price change was -0.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

ANVS is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($910M) has a higher market cap than ANVS($44.6M). AMLX YTD gains are higher at: 169.841 vs. ANVS (-54.473). ANVS has higher annual earnings (EBITDA): -23.68M vs. AMLX (-196.3M). AMLX has more cash in the bank: 181M vs. ANVS (17.1M). ANVS has higher revenues than AMLX: ANVS (0) vs AMLX (-249K).
AMLXANVSAMLX / ANVS
Capitalization910M44.6M2,040%
EBITDA-196.3M-23.68M829%
Gain YTD169.841-54.473-312%
P/E Ratio2.81N/A-
Revenue-249K0-
Total Cash181M17.1M1,058%
Total Debt5.96MN/A-
TECHNICAL ANALYSIS
Technical Analysis
AMLXANVS
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 23 days ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
82%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LIMAX7.660.01
+0.13%
Cromwell Tran Sustainable Focus Investor
JGICX76.20N/A
N/A
Janus Henderson Growth And Income C
MPAIX28.97N/A
N/A
Morgan Stanley Inst Advantage I
SCSDX18.74N/A
N/A
Allspring Common Stock Admin
FSTLX34.77N/A
N/A
Federated Hermes MDT Large Cap Value R6

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with GRI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+2.51%
GRI - AMLX
57%
Loosely correlated
+10.67%
SLRX - AMLX
54%
Loosely correlated
-0.63%
RGNX - AMLX
46%
Loosely correlated
+3.08%
LRMR - AMLX
44%
Loosely correlated
+1.81%
OCUL - AMLX
44%
Loosely correlated
+7.09%
More

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
+0.44%
ADXN - ANVS
43%
Loosely correlated
N/A
AMLX - ANVS
40%
Loosely correlated
+2.51%
ATXS - ANVS
36%
Loosely correlated
+7.43%
RXRX - ANVS
36%
Loosely correlated
+1.99%
ANNX - ANVS
35%
Loosely correlated
+0.93%
More